|
Originally published In Press as doi:10.1074/jbc.M003507200 on July 31, 2000
J. Biol. Chem., Vol. 275, Issue 42, 32861-32870, October 20, 2000
Molecular Defects That Cause Loss of Polysialic Acid in the
Complementation Group 2A10*
Michaela
Windfuhr ,
Arnd
Manegold ,
Martina
Mühlenhoff ,
Matthias
Eckhardt§, and
Rita
Gerardy-Schahn ¶
From the Institut für Medizinische
Mikrobiologie, Medizinische Hochschule Hannover, Carl-Neuberg-Strasse
1, 30625 Hannover and the § Institut für
Physiologische Chemie, Universität Bonn, Nußallee 11,
53115 Bonn, Germany
Received for publication, April 25, 2000, and in revised form, July 25, 2000
 |
ABSTRACT |
Polysialic acid (PSA) is a dynamically regulated
posttranslational modification of the neural cell adhesion molecule
(NCAM), which modulates NCAM binding functions. PSA biosynthesis is
catalyzed by two polysialyltransferases, ST8SiaII and ST8SiaIV. The
catalytic mechanisms of these enzymes are unknown. In Chinese hamster
ovary cells, ST8SiaIV is responsible for PSA expression. In the
complementation group 2A10, the ST8SiaIV gene is disrupted.
Investigating the molecular defects in this complementation group,
seven clones with missense mutations in ST8SiaIV were found. Mutations
cause replacement of amino acids that are highly conserved in
2,8-sialyltransferases. To verify the physiological relevance of
identified mutations, identical amino acid substitutions were
introduced into epitope-tagged variants of hamster ST8SiaIV and murine
ST8SiaII and recombinant proteins were tested in vivo and
in vitro. None of these constructs reconstituted PSA
synthesis in 2A10 cells, although the proteins were expressed and with
the exception of the cysteine variants ST8SiaIV-C356F and
ST8SiaII-C371F correctly targeted to the Golgi apparatus.
Interestingly, two mutations (ST8SiaIV-R277G and -M333V and the
corresponding mutants ST8SiaII-R292G and -M348V) could be partially
rescued if tested in vitro. Although these mutants were
negative for autopolysialylation, partial reconstitution of both auto-
and NCAM polysialylation was achieved in the presence of NCAM. The data
presented in this study suggest a functional link between auto- and
NCAM polysialylation.
 |
INTRODUCTION |
Rapid changes in cellular recognition events as required in the
course of development (1, 2), inflammation (3), and regeneration (4)
can be realized via structural variations of plasma membrane components
(e.g. by changing their glycosylation patterns) leading to
modified binding capacities. One of the most intensively studied
examples in this context is the neural cell adhesion molecule
(NCAM).1 NCAM belongs to the
superfamily of immunoglobulin (Ig)-like cell adhesion molecules and
contains five Ig and two fibronectin type III homology domains in the
extracellular part (5). NCAM mediates homo- and heterophilic binding
interactions (6, 7) but, in contrast to other cell adhesion molecules,
bears a second regulatory quality, which is the destabilization of cell
contacts (8). Responsible for the latter function is polysialic acid
(PSA), a unique posttranslational modification of NCAM (for review, see Refs. 9-11). PSA is a large homopolymer of 2,8-linked
N-acetylneuraminic acid. PSA addition to NCAM is
developmentally (12, 13) and functionally (14, 15) regulated with
maximal expression in the perinatal phase. In the adult only brain
areas with persisting neurogenesis, cell migration (16), axonal growth
(17), and synaptic plasticity (for review, see Refs. 18 and 19) are PSA-positive. Neuroendocrine tumors of high malignant potential, like
small cell lung cancer (20, 21), neuroblastoma (22, 23), and Wilms'
tumor (24) reexpress PSA at high concentrations, and recent studies
demonstrate that PSA promotes tumor growth and malignancy (20, 22,
25).
PSA synthesis in mammals involves two closely related, but
independently expressed polysialyltransferases (see Ref. 26, and
literature cited therein), ST8SiaII, formerly named STX, and ST8SiaIV,
formerly named PST-1 or PST (for review, see Ref. 27). The modi of
operation of ST8SiaII and ST8SiaIV seem to be very similar, if not
identical. Minor differences have been described with respect to NCAM
isoform specificity and length of PSA chains synthesized (28, 29). A
very recent study describes ST8SiaII and ST8SiaIV to have different
affinities for the two PSA acceptor sites within the NCAM molecule.
Co-expression of both polysialyltransferases led to maximal PSA
expression in transfected cells (30).
The catalytic mechanisms used by polysialyltransferases are still
obscure, and nothing is known about the structural elements that
separate polysialyltransferases from other sialyltransferases. Recently, we reported an unusual autocatalytic property of ST8SiaIV termed "autopolysialylation" (31). PSA synthesis in this reaction involves N-glycosylation sites present in the enzyme.
Moreover, because soluble forms of the recombinant ST8SiaIV isolated
from the supernatant of transfected Chinese hamster ovary (CHO)-K1 cells were found to carry PSA and immaturely glycosylated enzyme forms
were shown to be inactive, this study already demonstrated that
autopolysialylation occurs at the cellular level and is a prerequisite
for an active enzyme. Later studies confirmed autopolysialylation for
ST8SiaII and ST8SiaIV (30, 32), and a recent study shows that in human
ST8SiaIV asparagine 74 is the major acceptor site for autocatalytically
produced PSA (33).
CHO cells of the complementation group 2A10 exhibit a defect in the
ST8SiaIV gene and are PSA-negative (34). In this study the molecular
defects that inactivate ST8SiaIV in 2A10 cells have been analyzed. In a
panel of 31 clones, 7 were found to be inactive due to missense
mutations in ST8SiaIV. Amino acid replacements caused by the mutations
in all cases concern positions that are highly conserved in the family
of 2,8-sialyltransferases. Five mutations inactivate ST8SiaIV
completely, whereas two were found to affect mainly the
autopolysialylation capacity. Mutations identified in ST8SiaIV were
introduced in ST8SiaII and caused identical defects. With this study we
confirm earlier data suggesting a functional link between auto- and
NCAM polysialylation (31, 33).
 |
EXPERIMENTAL PROCEDURES |
Materials--
Monoclonal antibodies (mAb) 735 (murine IgG2a)
directed against PSA (35), 9E10 (murine IgG1) directed against the Myc
epitope (EQKLISEEDLN), and KD11 (murine IgG1) directed against
transmembrane forms of NCAM (36) were used after purification on
protein G-Sepharose (Amersham Pharmacia Biotech). MAb 12CA5 (murine
IgG2b) directed against the hemagglutinin (HA) epitope (YPYDVPDYASL)
was purchased from Roche (Penzberg, Germany), and mAb M5 (murine IgG1)
directed against the Flag sequence (MDYKDDDDK) was from Sigma
(Deisenhofen, Germany). A polyclonal rabbit antiserum recognizing the
luminal part of -mannosidase II (37) was a kind gift of Dr. K. Moremen (University of Georgia, Athens, GA). Secondary antibodies
anti-mouse Ig-alkaline phosphatase (AP) conjugate, anti-mouse
Ig-dichlorotriazinyl aminofluorescein (DTAF) conjugate and anti-rabbit
Ig-tetramethyl rhodamine isothiocyanate (TRITC) conjugate were from
Dianova (Hamburg, Germany) and anti-digoxigenin Ig-AP conjugate from
Roche (Penzberg, Germany). Endoneuraminidase NE (endoNE) was purified
from PKE1-phage lysates (38). CMP-[14C]Neu5Ac (10.5 GBq/mmol) was purchased from Amersham Pharmacia Biotech.
Cell Lines--
CHO-K1 cells were obtained from the American
Type Culture Collection (Rockville, MD). 2A10 cells represent a genetic
complementation group, which is PSA-negative due to defects in ST8SiaIV
(34). 31 individual 2A10 clones were isolated from chemically
mutagenized CHO-K1 cells. Wild type CHO cells and 2A10 mutants were
maintained in DMEM/Ham's F12 (1:1; Seromed) supplemented with 5%
fetal calf serum (FCS), 1 mM sodium pyruvate, 100 units/ml
penicillin, and 100 µg/ml streptomycin in a 37 °C, 5%
CO2 incubator. NIH3T3 cells were maintained in Dulbecco's
modified Eagle's medium (Seromed) supplemented with 10% FCS, 1 mM sodium pyruvate, 100 units/ml penicillin, and 100 µg/ml streptomycin.
Northern Blot Analysis--
Total RNA was isolated from CHO-K1
and 2A10 cells by guanidinium isothiocyanate extraction and
centrifugation through CsCl gradients (39). Polyadenylated RNA
(mRNA) was isolated from total RNA using Oligotex beads (Qiagen)
according to the manufacturers' instructions. The purification step
was carried out twice to obtain poly(A)+ RNA. 4 µg of
poly(A)+ RNA were fractionated on 1% agarose, 1 M formaldehyde gels and transferred onto nylon membranes
(Qiagen). Blots were hybridized with a digoxigenin-labeled antisense
RNA probe transcribed from the entire coding region of the hamster
ST8SiaIV cDNA (34). Hybridization was performed overnight at
65 °C in 5× standard saline citrate (5× SSC: 50 mM
sodium phosphate, 7% SDS, 50% formamide) and 1% blocking reagent
(Roche). Membranes were washed twice for 10 min in 2× SSC, 0.1% SDS
at room temperature and once in 0.1× SSC, 0.1% SDS at 68 °C for 20 min. Membranes were incubated with anti-digoxigenin Ig-AP conjugate and
bound RNA probes displayed by chemiluminescence using
disodium-3-(4-methoxyspiro(1,2-dioxetane-3,2'-(5'-chloro)tricyclo-(3.3.1.13,
7)decan)-4-yl)phenylphosphate (Roche) as a substrate.
Isolation of Mutant ST8SiaIV cDNAs from 2A10 Cells by Reverse
Transcription and Polymerase Chain Reaction
(RT-PCR)--
Oligonucleotide primers used in this study are listed in
Table I. The table also details the
localization and orientation of the primers.
1 µg of poly(A)+ RNA was reverse transcribed with 200 units of SuperscriptTMII RNase H reverse transcriptase
(Life Technologies, Inc.) using primer ME54. Full-length cDNAs were
then amplified by PCR using primers ME21 and ME22. The amplification
was carried out for 40 cycles with Taq DNA polymerase
(Sigma) and 80 s of elongation time. PCR products were
electrophoresed on an agarose gel and cDNAs of the expected size
excised and extracted using GFXTM PCR DNA and gel band purification
kit (Amersham Pharmacia Biotech). To increase the yield of PCR
products, gel-extracted cDNAs were used as a template in a second
amplification round (40 cycles) with the same primer combination. PCR
products were purified by electrophoresis, extracted from the gel as
described, and ligated into the vector pGEM® T (Promega).
The nucleotide sequences were determined by the dideoxy chain
termination method (40) using -[35S]dATP (Amersham
Pharmacia Biotech) and T7 DNA polymerase (Amersham Pharmacia Biotech).
Construction of Epitope-tagged Forms of ST8SiaII and
ST8SiaIV--
Wild type and mutant forms of ST8SiaII and ST8SiaIV were
tested for enzymatic activity in vitro and in
vivo. Therefore, two sets of epitope-tagged proteins were
constructed: (i) full-length forms with N-terminal Flag-HA tags and
(ii) soluble forms with C-terminal Myc-His epitopes.
To generate the N-terminally Flag-HA-tagged full-length constructs, the
entire coding sequences of murine ST8SiaII and hamster ST8SiaIV were
amplified by PCR without the start codons using Pfu DNA
polymerase (Promega) with primers MW28 and MM32 for ST8SiaII and
primers MW5 and AB6 for ST8SiaIV. PCR products were ligated into the
XhoI/XbaI sites of vector pcDNA3-Flag-HA.
pcDNA3-Flag-HA is a derivative of the vector pcDNA3
(Invitrogen), obtained after ligating the Flag-adaptor sequence
MDYKDDDDK (encoded by the oligonucleotides FlagM5as
(5'-GATCCCTTATCATCATCATCCTTGTAGTCCATGGTGGCGGTAC-3') and FlagM5s
(5'-CGCCACCATGGACTACAAGGATGATGATGATAAGG-3')) into the KpnI/BamHI sites and the HA-adapter sequence
YPYDVPDYASL (encoded by the oligonucleotides HABglIIs
(5'-GATCTTACCCTTATGACGTCCCCGATTACGCCAGCCTGC-3') and
HANotIas (5'-GGCCGCAGGCTGGCGTAATCGGGGACGTCATAAGGGTAA-3')) into the BamHI/NotI sites of pcDNA3.
Vector constructs harboring the full-length wild type
polysialyltransferases were named pFlag-HA-ST8SiaII and
pFlag-HA-ST8SiaIV.
Soluble forms of C-terminally Myc-His-tagged ST8SiaII and ST8SiaIV were
generated with the aid of the vector pSecTag B (Invitrogen). Nucleotides 94-1125 of murine ST8SiaII and nucleotides 76-1077 of
hamster ST8SiaIV were amplified by PCR with primer pairs MM29/MM30 and
MM26/MM31, respectively. Fragments obtained after
BamHI/XbaI digestion were cloned into the
according vector sites. Vector constructs allow the translation of
proteins, in which the cytoplasmic and transmembrane domains (amino
acids 1-31 in ST8SiaII, and 1-25 in ST8SiaIV) are substituted by the
signal sequence of the Ig light chain and which contain Myc-His
epitopes at the C terminus. The plasmids containing the wild type
sequences were named pMyc-ST8SiaII and pMyc-ST8SiaIV. All constructs
were confirmed by sequencing.
Generation of ST8SiaII and ST8SiaIV Mutants--
ST8SiaIV
mutations identified in clones of the 2A10 complementation group were
introduced into the wild type sequences of pFlag-HA-ST8SiaII,
pFlag-HA-ST8SiaIV, pMyc-ST8SiaII, and pMyc-ST8SiaIV by either
subcloning of restriction fragments or site directed mutagenesis. All
constructs were confirmed by sequencing. Details concerning the
construction of mutants are available upon request.
Production of Recombinant Epitope-tagged ST8SiaII and ST8SiaIV
Variants--
Soluble Myc-tagged forms of wild type and mutant
ST8SiaII and ST8SiaIV were immunoisolated from the supernatants of
transiently transfected 2A10 cells. Transfections were carried out with
LipofectAMINETM (Life Technologies, Inc.). Briefly,
2.4×106 cells were seeded in 10-cm tissue culture dishes
and incubated for 18 h at 37 °C, 5% CO2. Cells
were rinsed with phosphate-buffered saline (PBS) and for transfection
overlaid with a mixture consisting of 6 µg of DNA and 24 µl of
LipofectAMINETM in 4 ml of OptiMEM I (Life Technologies). After 6 h at 37 °C and 5% CO2, 4 ml of medium with 10% FCS
were added, and the cells were incubated for another 18 h.
Thereafter, the medium was exchanged against 8 ml of medium containing
5% FCS and incubation continued. After 48 h, the supernatants
were collected and fusion proteins were immunoisolated with the
anti-Myc mAb 9E10 covalently coupled to protein G-Sepharose beads
(Amersham Pharmacia Biotech). 10 µl of 9E10-coated beads were used
per 6 ml of supernatant.
In Vitro Assay for Polysialyltransferase Activity--
Auto- and
NCAM polysialylation were analyzed in vitro using the
soluble Myc-tagged polysialyltransferases. MAb 9E10 covalently bound to
protein G-Sepharose was used to immunoisolate epitope-tagged proteins
from the supernatants of transiently transfected 2A10 cells. Beads were
washed three times with reaction buffer (10 mM sodium
cacodylate, pH 6.0, 10 mM MnCl2) and subdivided
into three equal aliquots. In aliquot 1, autopolysialylation was
started by addition of 5.55 kBq of CMP-[14C]Neu5Ac in a
final volume of 60 µl of reaction buffer. After 2 h at 37 °C,
the reaction was stopped by washing twice with PBS and adding 20 µl
of Laemmli buffer (41) with 5% (v/v) -mercaptoethanol. Samples were
heated to 65 °C for 20 min and analyzed by 7% SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and autoradiography.
For the NCAM polysialylation assay, the remaining two aliquots of the
bead fraction preloaded with the recombinant polysialyltransferases were used to extract a soluble protein A-NCAM fusion protein from the
supernatant of transfected 2A10 cells as described previously (31). The assay was performed as described for
autopolysialylation. To control the specificity of the reaction
product, one aliquot was treated with endoNE (100 ng of endoNE in 60 µl of PBS, 37 °C, 30 min) before loading on a 7% SDS-PAGE.
Samples were displayed by autoradiography.
In order to make results obtained in the auto- and NCAM polysialylation
assay comparable, dried gels were exposed in parallel to the same film.
SDS-PAGE, Autoradiography, and Western Blot
Analysis--
SDS-PAGE was performed according to Laemmli (41) in 7%
or 9.5% gels under reducing conditions. Gels were either vacuum-dried and exposed (4 weeks) on Hyperfilm MP (Amersham Pharmacia Biotech) for
autoradiography or used to transfer proteins onto nitrocellulose membranes for Western blot analysis. Western blots were developed as
follows. Membranes were blocked for 30 min in blocking solution A (2%
nonfat dry milk in PBS) and incubated for 2 h with the primary antibody diluted in blocking solution A (5 µg/ml mAb 735 and KD11, 2.5 µg/ml mAb M5, 1.5 µg/ml mAb 9E10). Blots were washed three times in PBS and incubated for 1 h with the secondary antibody (anti-mouse Ig-AP conjugate 1:2000 in blocking solution A). Thereafter, blots were washed twice with PBS and once with AP buffer (100 mM Tris-HCl, pH 9.5, 100 mM NaCl, 5 mM MgCl2) and bound secondary antibody-conjugates displayed with nitro blue tetrazolium and 5-bromo-4-chloro-3-indolyl phosphate as substrates.
Indirect Immunofluorescence--
Variant forms of
pFlagHA-ST8SiaII and pFlagHA-ST8SiaIV were transiently transfected into
NIH3T3 cells using EffecteneTM (Qiagen). Glass coverslips were placed
into 12-well plates, and 2×104 cells were seeded per well.
Cells were incubated for 18 h (37 °C and 5% CO2).
Transfections were carried out with 0.16 µg of DNA, 75 µl of buffer
EC, 1.76 µl of Enhancer, and 1.67 µl of EffecteneTM in 400 µl of
medium according to the manufacturers' instructions. Cells on
coverslips were washed three times with PBS, fixed in 4%
paraformaldehyde for 20 min, washed in PBS, and permeabilized with
0.2% Triton X-100 in PBS for 9 min. After three additional washes with
PBS, cells were incubated for 15 min at 37 °C in blocking solution B
(20% horse serum in PBS), washed with PBS, and incubated for 2 h
at 37 °C with the primary antibody diluted in blocking solution B
(mAb M5, 2.5 µg/ml; -mannosidase II antiserum, 1:2000). After
three washing steps with PBS, cells were incubated for 2 h at
37 °C with anti-mouse Ig-DTAF or anti-rabbit Ig-TRITC, each diluted
1:200 in blocking solution B. Cells were finally washed three times in
PBS, rinsed in water, and mounted in Mowiol. Samples were visualized
under a Zeiss Axiophot epifluorescence microscope.
 |
RESULTS |
Mutants of the Complementation Group 2A10--
CHO mutants
belonging to the complementation group 2A10 are characterized by a loss
of PSA expression. 2A10 cells were used to isolate ST8SiaIV, the only
polysialyltransferase expressed in CHO cells (34). The molecular
defects causing loss of PSA expression in 2A10 cells were investigated
in this study. First, the presence of ST8SiaIV mRNA was analyzed.
The Northern blot in Fig. 1 shows that
wild type (wt) CHO cells express two ST8SiaIV mRNAs of about 6.5 and 2.3 kilobase pairs. In only 3 out of 31 2A10 clones were
ST8SiaIV-specific hybridization signals detectable, and only 1 clone
(7G11) gave a band pattern identical to the wild type. In clone 8F8,
the upper band was drastically reduced and migrated slightly faster
than the corresponding wt band. In clone 2A10, a weak 6.5-kilobase pair
signal was visible. The majority of clones, however, were negative in
Northern blot analysis (see, e.g., clone 9G2 in Fig. 1).
RT-PCR was used to reinvestigate the presence of ST8SiaIV mRNA in
2A10 cells. Six additional clones (2D8, 4C4, 5C3, 7F11, 9C8, and 9D8)
were found to be positive for ST8SiaIV transcripts (data not
shown).

View larger version (76K):
[in this window]
[in a new window]
|
Fig. 1.
Northern blot analysis of CHO wt cells and
2A10 mutants. 4 µg of poly(A)+ RNA were loaded per
lane. The hybridization was carried out with a digoxigenin-labeled
antisense RNA probe transcribed from the entire coding region of the
hamster ST8SiaIV. Results are shown for clones 2A10, 7G11, 8F8, and
9G2. Equal loading of the gel was controlled by reprobing the blot with
an antisense RNA directed against glyceraldehyde-3-phosphate
dehydrogenase (GAPDH).
|
|
To determine the sequence of ST8SiaIV-transcripts present in 2A10
mutants, RT-PCR products were subcloned and individual colonies were
sequenced. RT-PCR and sequencing were carried out at least twice in
parallel samples to eliminate PCR artifacts. Mutations identified are
listed in Table II. Single point
mutations that allow the translation of full-length proteins with
single amino acid exchanges were found in six clones. In clone 2D8 the
simultaneous occurrence of a nucleotide transition (A997G) and
transversion (G1067T) led to the amino acid exchanges M333V and C356F,
respectively. The nucleotide transition C103T introduces a premature
stop codon in clone 2A10. In clone 8F8 skipping of exon 3 inactivates
ST8SiaIV. It is likely that an element involved in RNA-splicing
(e.g. splice donor or acceptor site) is destroyed at the
genomic level.
View this table:
[in this window]
[in a new window]
|
Table II
ST8SiaIV mutations identified in cells of the complementation group
2A10
, deletion; amino acid residues are given in the single-letter code.
|
|
Missense mutations identified in 2A10 cells are displayed in Fig.
2. All cause the exchange of amino acids
that are highly conserved in the subfamily of
2,8-sialyltransferases. Only methionine 333 is leucine in ST8SiaIII,
and only glycine 281 is invariant in all sialyltransferases. Glycine
146 and glutamic acid 336 are also found in other sialyltransferases,
whereas threonine 189, arginine 277, and cysteine 356 are restricted to
2,8-sialyltransferases. These positions may, therefore, contribute
to the determination of 2,8 linkage specificity.

View larger version (76K):
[in this window]
[in a new window]
|
Fig. 2.
Primary sequence alignment of
sialyltransferases. To evaluate the importance of mutated
positions identified in ST8SiaIV, the conservation of these residues
was analyzed via primary sequence alignments in the family of
sialyltransferases. Because more than 50 sialyltransferase sequences
are available in the data bases, only the murine sequences are
displayed for sialyltransferases with specificities different from
2,8. Members of the 2,8 subfamily are shown in complete.
Positions mutated in 2A10 are boxed, and amino acid
exchanges are given as bold letters in the
bottom lane. 2A10 mutations localize
within or in close proximity to the three conserved sialylmotifs L, S
(black bars on top of sequences), and VS
(arrowheads). Nomenclature is according to Ref. 54.
|
|
Site-directed Mutation of ST8SiaIV--
From the finding that
ST8SiaIV mRNA levels are drastically reduced in 2A10 clones (see
Fig. 1), the possibility arises that loss of PSA expression is due to
subthreshold expression of mutated proteins. To investigate this
possibility, recombinant ST8SiaIV variants were generated and enzymatic
activity was tested in vivo and in vitro. To
decide on the importance of each of the two mutations found in clone
2D8, the amino acid exchanges were separately introduced into the wild
type enzyme. The full-length ST8SiaIV cDNA cloned into the vector
pcDNA3-Flag-HA was subject of site-directed mutagenesis. Mutations
were verified by sequencing and cDNAs transiently expressed in 2A10
cells. 48 h after transfection, whole cell lysates were analyzed
in Western blot with the mAb 735 to display PSA (35) and with mAb KD11
to display NCAM (36). As shown in Fig.
3A, 2A10 cells express the
NCAM isoforms 140 and 180. NCAM bands are present at comparable
concentrations in all samples and demonstrate equal loading of the gel.
A broad microheterogeneous signal representing polysialylated NCAM
could be detected in 2A10 cells transfected with wt Flag-HA-ST8SiaIV,
and a very weak PSA signal was visible in cells transfected with the
mutant R277G (see Fig. 3A). None of the other ST8SiaIV
variants was able to reconstitute PSA expression in 2A10 cells. The two
mutations observed in clone 2D8 independently inactivate ST8SiaIV (see
M333V and C356F in Fig. 3), and therefore were investigated separately
in subsequent experiments. To control the expression of recombinant
Flag-HA-ST8SiaIV proteins, aliquots of the cell lysates were
immunoprecipitated with anti-HA mAb 12CA5 and analyzed in Western blot
with anti-Flag mAb M5. Wild type and mutant proteins were expressed,
indicating that not absence of proteins but mutations in ST8SiaIV are
responsible for the lack of PSA expression. Double or triplet bands
visible in Fig. 3B represent nascent, incompletely
glycosylated Flag-HA-ST8SiaIV proteins.

View larger version (29K):
[in this window]
[in a new window]
|
Fig. 3.
Overexpression of ST8SiaIV variants in 2A10
cells. Full-length constructs of wild type and mutants were cloned
into the vector pcDNA3-Flag-HA used for transient transfection of
2A10 cells. 2 days after transfection, cells were analyzed for the
presence of PSA. A, Western blot analysis of whole cell
lysates. The blot was stained simultaneously with mAb 735 to display
PSA and mAb KD11 to display NCAM. Equality of NCAM bands confirmed
equal loading of the gel. PSA was detectable in cells transfected with
wt ST8SiaIV, and a very faint signal could be seen in the case of the
mutant R277G. B, Western blot of ST8SiaIV variants.
Recombinant proteins were immunoprecipitated from an aliquot of the
lysates described in A using the anti-HA mAb 12CA5 and
stained in Western blot with the anti-Flag mAb M5 to display
expression. The multiband patterns represent nascent incompletely
glycosylated ST8SiaIV proteins.
|
|
It is important to mention, at this point, that differences in the
protein expression levels (e.g. see Fig. 3B and
subsequent experiments) are due to the experimental system and varied
between parallel experiments, but did not affect their results.
Introduction of 2A10 Mutations into ST8SiaII--
In mammals a
second polysialyltransferase, ST8SiaII, exists, which is closely
related to ST8SiaIV at primary sequence level and with respect to
catalytic functions (28-30). In order to test the functional
consequences of 2A10 mutations in ST8SiaII, identical amino
acid exchanges were carried out in the construct Flag-HA-ST8SiaII and
mutants were tested for complementation in 2A10 cells. The results are
summarized in Fig. 4. Wild type and
mutant Flag-HA-ST8SiaII proteins were expressed (Fig. 4B),
but only wt Flag-HA-ST8SiaII was able to reconstitute PSA expression in
2A10 cells (Fig. 4A). In contrast to ST8SiaIV-R277G, the
corresponding mutant ST8SiaII-R292G was negative.

View larger version (26K):
[in this window]
[in a new window]
|
Fig. 4.
Overexpression of ST8SiaII variants in 2A10
cells. Full-length constructs of wild type and mutants were cloned
into the vector pcDNA3-Flag-HA and used for transient transfection
of 2A10 cells. 2 days after transfection, cells were analyzed for the
presence of PSA. A, Western blot analysis of whole cell
lysates stained with the anti-PSA mAb 735 and the anti-NCAM mAb KD11.
PSA is present in cells transfected with wt Flag-HA-ST8SiaII
exclusively. Equality of NCAM bands confirms equal loading of the gel.
B, Western blot of the recombinant ST8SiaII variants.
Proteins were immunoisolated from the cell lysates described in
A using the anti-HA mAb 12CA5 and stained with anti-Flag mAb
M5. All proteins are expressed. The multiband patterns represent
nascent incompletely glycosylated ST8SiaII proteins.
|
|
In Vitro Rescue of ST8SiaIV Mutants R277G and M333V and of ST8SiaII
Mutants R292G and M348V--
Recently we demonstrated that active
polysialyltransferases exhibit a second catalytic function, termed
autopolysialylation (31). Although the mechanism and the biological
relevance of the autopolysialylation reaction are not understood, our
earlier experiments carried out in vitro suggested a tight
link between these two catalytic functions (31).
Asking whether 2A10 mutations affect the autocatalytic
activity, wild type and mutant polysialyltransferases were analyzed in vitro for their capacity to catalyze autopolysialylation.
For this assay the anti-Myc mAb 9E10, covalently bound to protein G-Sepharose, was used to immunoisolate soluble, C-terminally
Myc-His-tagged forms of the polysialyltransferases from the
supernatants of transfected cells. The reaction was carried out with
solid phase-fixed enzymes in the presence of the radioactive sugar
donor substrate CMP-[14C]Neu5Ac. After a 2-h incubation,
reactions were stopped and products displayed by SDS-PAGE and autoradiography.
Intensive, microheterogeneous radioactive signals became visible for
the wild type polysialyltransferases and represent autopolysialylation (Figs. 5A and 6A).
None of the mutants was able to perform autopolysialylation, albeit
very faint and focused radioactive bands were discernible for ST8SiaIV
mutants R277G and M333V (see Fig. 5A). The absence of
radioactive PSA bands for the mutant ST8SiaIV-C356F can be explained by
absence of secreted protein. All other variants were present in the
supernatants of transfected 2A10 cells (Figs. 5C and
6C). It is worthwhile to mention that in all experiments
secreted forms of the recombinant ST8SiaII proteins were found to be
expressed at a higher level than the respective ST8SiaIV proteins. The
difference is pronounced in the case of the mutants ST8SiaIV-C356F and
ST8SiaII-C371F (compare Figs. 5C and 6C).
However, if expression of recombinant proteins was analyzed inside
transfected cells, ST8SiaIV-C356F was expressed at the same level as
other proteins. The Western blots in Figs. 5D and
6D show Myc-His-tagged proteins immunoprecipitated with mAb
9E10 from whole cell lysates. The multiband patterns represent nascent
immaturely glycosylated proteins.

View larger version (50K):
[in this window]
[in a new window]
|
Fig. 5.
In vitro analysis of ST8SiaIV
mutants for auto- and NCAM polysialylation. Secreted C-terminally
Myc-His-tagged forms of wild type and mutant ST8SiaIV were used to
investigate auto- and NCAM polysialylation in vitro.
A, Autopolysialylation was carried out with solid phase
bound enzymes in the presence of CMP-[14C]Neu5Ac, samples
were separated on 7% SDS-PAGE and developed by autoradiography. A
heterogeneous signal representing autopolysialylation is restricted to
wt ST8SiaIV, whereas week and discrete signals are visible for the
mutants R277G and M333V. Mutants T189I and C356F are completely
negative. B, bead-coupled enzymes were used to test PSA
synthesis in the presence of protein A-NCAM and samples were separated
on 7% SDS-PAGE. A broad radioactive signal caused by auto- and NCAM
polysialylation is visible before endoNE digestion ( ) with the wild
type enzyme and to gradually lower extents with the mutants R277G and
M333V. EndoNE digestion (+) displays residually sialylated NCAM and
polysialyltransferase bands. C, Western blot analysis was
used to control the loading of enzyme carrying beads. Proteins were
displayed with anti-Myc mAb 9E10. Wild type and mutant proteins with
the exception of C356F could be isolated from the supernatant of
transfected cells. D, Western blot showing nascent ST8SiaIV
variants immunoprecipitated from lysates of transfected cells and
displayed with anti-Myc mAb 9E10. All proteins including mutant C356F
are present at comparable levels inside the cells.
|
|
In order to test NCAM polysialylation, the solid phase fixed enzyme
fractions described above were used to extract a protein A-NCAM chimera
(NCAM fused to the IgG-binding domain of protein A). In this way we
achieved co-fixation of NCAM and polysialyltransferase on a solid
surface. Reactions were started by adding
CMP-[14C]Neu5Ac, and samples were analyzed by SDS-PAGE
and autoradiography. Surprisingly, the arginine and methionine mutants
(ST8SiaIV-R277G, ST8SiaIV-M333V, ST8SiaII-R292G, and ST8SiaII-M348V)
regained catalytic activity. Although PSA synthesis was decreased
compared with the wild type, treatment of the samples with PSA-specific
endoneuraminidase NE (38) clearly documented the presence of PSA (Figs.
5B and 6B). Most important, all
polysialyltransferases that were able to add PSA to NCAM incorporated
radioactive sugars also by themselves, indicating that NCAM
polysialylation is accompanied by autopolysialylation. Signals
representing self-modification are very faint in the case of the
ST8SiaII mutants R292G and M348V (see Fig.
6B). All other mutants listed
in Table II were negative for both auto- and NCAM polysialylation, as
shown for ST8SiaIV-T189I and ST8SiaII-T204I.

View larger version (44K):
[in this window]
[in a new window]
|
Fig. 6.
In vitro analysis of ST8SiaII
mutants for auto- and NCAM polysialylation. Secreted C-terminally
Myc-His-tagged forms of wild type and mutant ST8SiaII were used to
investigate auto- and NCAM polysialylation in vitro.
A, autopolysialylation was carried out with solid
phase-bound enzymes in the presence of CMP-[14C]Neu5Ac;
samples were separated on 7% SDS-PAGE and developed by
autoradiography. A radioactive signal representing autopolysialylation
is present in the case of the wild type enzyme. Mutants are unable to
perform autopolysialylation. B, bead-coupled enzymes were
used to test PSA synthesis in the presence of protein A-NCAM and
samples were separated on 7% SDS-PAGE. Radioactively labeled
heterogeneous bands appear with wild type and with mutants R292G and
M348V. The disperse appearance of radioactive bands is reduced after
endoNE treatment (+). Automodified ST8SiaII is visible in the lower
molecular weight range. Bands arising from self-modification are very
faint in the case of mutants R292G and M348V. C, equal
loading of enzyme carrying beads was controlled by Western blot
analysis. Proteins were displayed with anti-Myc mAb 9E10. Mutant C371F
is present at low concentration only. All the other proteins are
expressed at wild type level. D, nascent ST8SiaII variants
were precipitated from lysates of transfected cells and displayed in
Western blot with anti-Myc mAb 9E10. Proteins are present at comparable
levels inside the cells.
|
|
Leucine in Position 333 of ST8SiaIV Reconstitutes Biological
Activity--
The position corresponding to amino acid 333 in ST8SiaIV
is occupied by methionine in all 2,8-sialyltransferases except
ST8SiaIII, where leucine is found in this position (see Fig. 2).
According to sequence alignments, ST8SiaIII, which is active on
glycolipids, is the closest relative of the polysialyltransferases
(42). The biological role of this enzyme is, however, still unclear (for review, see Ref. 27). Since replacement of methionine 333 by
valine abolished the activity of ST8SiaIV in vivo we
analyzed the functional consequence of leucine in this position.
Soluble Myc-His-tagged ST8SiaIV-M333L was generated and tested in
comparison to the soluble forms of ST8SiaIV-M333V and wild type.
Results are summarized in Fig. 7.
Although ST8SiaIV-M333V was inactive, the mutant ST8SiaIV-M333L was
able to complement the defect of 2A10 cells, albeit the PSA signal was
reduced in comparison to the wild type enzyme (Fig. 7A).
Under in vitro conditions, mutant M333L behaved like wild
type in auto- and NCAM polysialylation (Fig. 7, B and
C), whereas M333V showed the picture already observed in
Fig. 5B. These findings suggest that size and sterical
features of the methionine side chain but not the thioether function
are important in this position.

View larger version (35K):
[in this window]
[in a new window]
|
Fig. 7.
ST8SiaIV-M333L is an active enzyme.
A, Western blot analysis of 2A10 cells transiently
transfected with soluble Myc-His-tagged forms of wt ST8SiaIV and the
mutants M333V and M333L. Whole cell lysates were transferred to
nitrocellulose membranes after separation on SDS-PAGE and stained
simultaneously with the mAb 735 to display PSA and mAb KD11 to display
NCAM. Mutant M333L reconstitutes PSA expression in 2A10 cells. NCAM
bands of 180 and 140 kDa demonstrate equal loading of the gel.
B, autoradiographic image of the autopolysialylation
reaction. Autopolysialylation was tested with solid phase-bound enzymes
isolated from the supernatant of the transiently transfected 2A10 cells
shown in A. Whereas M333V is unable to perform
autopolysialylation, the mutant M333L behaves like wild type in
producing a broad radioactive band. C, autoradiographic
image of NCAM polysialylation. The reaction was carried out with solid
phase-fixed enzymes in the presence of protein A-NCAM. Samples were
analyzed by SDS-PAGE and autoradiography before ( ) and after (+)
endoNE digestion. Broad heterogeneous radioactive signals representing
an overlay of auto- and NCAM polysialylation are visible for the wild
type enzyme and for the mutant M333L. Although ST8SiaIV-M333V regains
activity under these assay conditions, the extend of PSA synthesis on
NCAM and on the mutant enzyme itself is diminished. D, equal
loading of enzyme-carrying beads was controlled by Western blot
analysis. Proteins were displayed with anti-Myc mAb 9E10. E,
nascent ST8SiaIV variants were precipitated from lysates of transfected
cells and displayed in Western blot with anti-Myc mAb 9E10. All
proteins are present inside the cells.
|
|
Subcellular Targeting of Mutant
Polysialyltransferases--
Because activity in
autopolysialylation-negative mutants could be partially restored
in vitro via intimate contact to the PSA acceptor NCAM, we
speculated that subcellular mistargeting may be responsible for their
lack of complementation activity in 2A10 cells. The subcellular
localization of mutant and wild type polysialyltransferases was,
therefore, analyzed by indirect immunofluorescence in NIH3T3 cells
transiently transfected with full-length N-terminally
Flag-HA-tagged proteins. 30 h after transfection, cells were fixed
in paraformaldehyde and permeabilized with Triton X-100. The
localization of the Flag epitope was visualized with anti-Flag mAb M5.
Simultaneously, the cells were stained with an antiserum directed
against -mannosidase II, a known marker for the Golgi apparatus
(43). With the exception of ST8SiaIV-C356F, all ST8SiaIV mutants
strictly co-localize with -mannosidase II (see Fig.
8). The staining of the endoplasmic
reticulum (ER) observed for ST8SiaIV-C356F together with the fact that
soluble forms of this protein were not secreted (see Fig.
5C) argues for a misfolded protein, which is retained in the
ER. The analogous series of ST8SiaII variants gave identical results
(data not shown). Although small amounts of the soluble form of
ST8SiaII-C371F could be isolated from the supernatant (see Fig.
6C), the full-length protein was retained in the ER. The
correct Golgi destination of autopolysialylation-negative mutants
together with the observation that activity could be restored in the
presence of NCAM provides evidence that these mutations influence the
development of a catalytically active enzyme but do not cause gross
misfolding of the protein.

View larger version (9K):
[in this window]
[in a new window]
|
Fig. 8.
Intracellular localization of wild type and
mutant ST8SiaIV. 2A10 cells on glass coverslips were transiently
transfected with Flag-HA-tagged variants of full-length ST8SiaIV. 1 day
after transfection, cells were fixed in paraformaldehyde and
permeabilized with Triton X-100. Cells were then subjected to indirect
immunofluorescence using anti-Flag mAb M5 and an antiserum against
-mannosidase II, a known marker for the Golgi apparatus. Bound
primary antibodies were visualized with anti-mouse Ig-DTAF and
anti-rabbit Ig-TRITC conjugates. The diffuse staining throughout the
cytoplasm suggests ER localization for the mutant C356F. All other
mutant proteins and the wild type co-localize with -mannosidase II
and demonstrate correct Golgi destination.
|
|
Overexpression of Mutant Polysialyltransferases Does Not Influence
the Activity of Wild Type Enzymes--
In earlier studies Golgi
retention has been demonstrated to depend on protein complex formation
(44, 45) and active glycosyltransferases were described to assemble
into functional complexes (for review, see Refs. 46 and 47). Assuming
complex formation as essential for the assembly of active
polysialyltransferases, we tested if overexpression of mutant proteins
could induce a dominant negative phenotype. Co-transfection experiments
were carried out using pFlag-HA-ST8SiaIV constructs. Constant amounts
of wild type together with increasing concentrations of the mutant
cDNAs were transiently transfected into PSA-negative 2A10 cells.
The ratio wild type to mutant cDNA was varied up to 1:100. The
total amount of cDNA was kept constant by supplementing a cDNA
library isolated from CHO wild type cells. Transfection efficiencies
were controlled in the same experiment by adding a constant amount of
-galactosidase (48).
None of the mutants was able to significantly reduce PSA synthesis
catalyzed by wt ST8SiaIV. PSA expression levels monitored in
immunohistochemistry and Western blot analysis were independent from
the concentration of the mutant proteins (data not shown). Possible
explanations for these negative results are as follows. (i) The active
unit of ST8SiaIV is the monomer. (ii) The intracellular concentration
of mutant proteins was still too low to disrupt functional complexes.
(iii) 2A10 mutants have lost their ability to organize in di- or
oligomeric complexes.
 |
DISCUSSION |
CHO cells of the complementation group 2A10 are PSA-negative due
to mutations in the ST8SiaIV gene. 2A10 cells have been isolated from
chemically mutated CHO-K1 cells and were used for complementation cloning of hamster ST8SiaIV (34). A panel of 31 2A10 clones, existing
in our laboratory, served as a source to identify primary sequence
elements of functional importance in ST8SiaIV. The majority of clones
harbors defects interfering with ST8SiaIV gene expression, since
Northern blot analysis and RT-PCR displayed mutated mRNAs in only
nine clones. Seven clones contained single point mutations; six of
those allow the translation of full-length mutated proteins. In clone
2D8 two mutations have been identified that both cause an inactivation
of ST8SiaIV (M333V and C356F). The occurrence of a premature stop after
threonine-34 and deletion of the amino acid stretch encoded by exon 3 inactivated ST8SiaIV in clones 2A10 and 8F8, respectively. An overview
of all mutants is given in Table II.
Mutated ST8SiaIV mRNAs, with the single exception of clone 7G11,
were found to be expressed at drastically reduced levels. This fact
prompted us to investigate whether the PSA-negative phenotypes of 2A10
cells result from subthreshold expression of mutant proteins. ST8SiaIV
and the corresponding ST8SiaII variants were generated as full-length
and soluble proteins, and their enzymatic activities were tested
in vivo and in vitro. Although mutation of the
C-terminal cysteines (position 356 in ST8SiaIV; 371 in ST8SiaII) gave
rise to unstable, ER-retained translation products, all other mutants
were efficiently translated and correctly targeted to the Golgi
apparatus or, in case of the soluble forms, secreted into the medium.
However, even after overexpression, none of the mutant proteins was
able to complement 2A10 cells.
Interestingly, all primary sequence positions found to be mutated in
2A10 clones are highly conserved in the subfamily of 2,8-sialyltransferases but to a lesser extent in other
sialyltransferases (see Fig. 2). From this observation the possibility
arises that some of the identified positions are involved in
determining 2,8 linkage specificity. Experiments aimed at
enlightening the functional role of the identified residues in more
detail belong to work in progress in our laboratory. Glycine 281 in
ST8SiaIV is part of the small sialylmotif and represents an invariant
position in all sialyltransferases. The replacement by serine as found in clone 5C3 completely abolished the activity of both
polysialyltransferases. In contrast, replacement of this glycine by
alanine as recently described for ST6GalI (49) gave an active enzyme
with Km values increased by factor of 3 for the two
substrates. The contribution of this position to the catalytic process
seems to be unequal in different sialyltransferases.
The exchange of cysteine to phenylalanine (ST8SiaIV-C356F and
ST8SiaII-C371F) concerns an amino acid residue, which is found in
2,8-sialyltransferases only. In order to find out whether the size
of the phenylalanine side chain per se is responsible for
the deleterious effect, cysteine 356 was replaced by serine, a polar
amino acid of the same size. A soluble form of the mutant protein was
unstable and not secreted to the supernatant of transfected cells (data
not shown). These data suggest that the thiol function is essential in
this position. Additional work is required to find out whether cysteine
356 is involved in the formation of a disulfide bridge or participates
in the catalytic reaction. Support for the latter assumption comes from
an earlier study that by the use of thiol-directed alkylating reagents
demonstrated that at least one cysteinyl residue is of critical
importance for polysialylation (50).
ST8SiaIV mutants R277G and M333V and the respective ST8SiaII mutants
R292G and M348V were unable to complement the defect of 2A10 cells, but
regained activity when assayed in vitro in the presence of
NCAM. Parallel tests for autopolysialylation were negative. The close
proximity between defective polysialyltransferases and NCAM under
in vitro conditions was sufficient to restore activity. Therefore, we hypothesize that primary sequence changes inhibit the
development of active enzyme conformations. The intimate contact with
the PSA acceptor NCAM (co-fixation of enzyme and acceptor on a solid
surface) partially compensates the loss of conformational integrity. In
the reconstituted systems both auto- and NCAM polysialylation were
visible, rising evidence that the two activities are tightly or
essentially linked (see Figs. 5B, 6B, and
7C). The experiments shown in Figs. 3A and
5A support this assumption. Mutant ST8SiaIV-R277G, which
preserved a residual competence to perform self-modification (see Fig.
5A), was able to produce small amounts of PSA after overexpression in 2A10 cells (Fig. 3A).
Activity of ST8SiaIV-M333V could be rescued by replacing valine by
leucine. Although methionine is slightly polar, it is mostly found in
the hydrophobic core of a protein and often substitutes for leucine,
isoleucine, or valine. The difference of M333L and M333V might be due
to the fact that neither methionine nor leucine shows a branching at
the -carbon, whereas valine does. This could implicate sterical
hindrance leading to slight misfolding of the protein. Another
interesting aspect is the position of methionine 333 between the two
highly conserved amino acids of the very short (VS; see Fig. 2)
sialylmotif (51). From clone 9C8 we isolated a second mutant,
ST8SiaIV-E336K, in which the VS motif is destroyed (see Table II).
Biologic activity of both mutated polysialyltransferases is abolished,
although the recombinant proteins are stable (Figs. 3B and
4B) and targeted to the Golgi apparatus (Fig. 8). Therefore, the mutation seems not to grossly affect folding but the catalytic activity. These data confirm the functional importance of the VS motif.
When we first reported on autopolysialylation (31), we suggested that
the autocatalytic maturation step is a prerequisite for the formation
of the active ST8SiaIV. Our argumentation was based on three
observations. 1) Recombinant wt ST8SiaIV generated in 2A10 cells
carries PSA and is an active enzyme. 2) Recombinant wt ST8SiaIV
generated as an asialo-glycoprotein from CMP-sialic acid transport
negative Lec2 cells (52) is able to perform autopolysialylation and is
an active enzyme. 3) Recombinant wild type ST8SiaIV generated as an
asialo-agalacto-glycoprotein from UDP-galactose transport negative Lec8
cells (53) is unable to perform autopolysialylation and unable to
polysialylate NCAM. Here we describe missense mutations that
drastically reduce (see Fig. 5; ST8SiaIV) or completely inactivate (see
Fig. 6; ST8SiaII) the autopolysialylation capacity of the polysialyltransferases. Defects in the primary sequence do not seem to
cause gross alterations in the proteins, because mutants are stable and
correctly targeted to their subcellular sites. Moreover, the artificial
contact between the mutant proteins and NCAM as established in the
in vitro assay system was sufficient to restore activity. A
potential explanation resides in the possibility that these
2A10 mutations cause the disorientation of
N-glycan(s) that are involved in the process of
autopolysialylation. Binding of NCAM seems to be sufficient to induce
the active conformation.
An important question in this context is: which of the five and six
potential N-glycosylation sites present in ST8SiaIV and ST8SiaII, respectively, are involved in the processes of auto- and NCAM
polysialylation? A recent study by Colley and co-workers (33) on human
ST8SiaIV identified the N-glycan bound to asparagine 74 as
the major acceptor of autocatalytically synthesized PSA. The
replacement of asparagine 74 by serine abolished autopolysialylation; however, NCAM polysialylation was retained, although at a very low
level. Based on their results, the authors suggest independence of the
two catalytic steps. A similar
study2 carried out in our
laboratory partially contradicts these results. Although we agree that
the oligosaccharide bound to asparagine 74 is the major carrier of
autocatalytically generated PSA, we see that the inactivation of this
site is not sufficient to abolish autopolysialylation.
From earlier studies (28, 30), we know that PSA chains produced by
ST8SiaIV are longer than those generated by ST8SiaII. This effect is
obvious in Figs. 5 and 6. Polysialylated proteins resulting from
ST8SiaIV catalysis shift to much higher molecular masses than those
resulting from ST8SiaII activity. Together with the fact that
autopolysialylation is reduced in the presence of NCAM (31), this
explains the difficulty to detect and display autopolysialylation in
ST8SiaII mutants. Nevertheless, weak but doubtless signals
demonstrating self-modification have been confirmed in repeated
experiments and prove the simultaneous occurrence of auto- and NCAM polysialylation.
The molecular analysis of the defects causing the functional
inactivation of ST8SiaIV in 2A10 cells led to the identification of
primary sequence elements that play key roles in the formation of
catalytically active polysialyltransferases. The study validates mutational analyses as an efficient strategy toward enlightening structure-function relationships in situations where other structural data are not available. Because some of the identified positions are
highly specific for 2,8-sialyltransferases, our data introduce a new
basis for studies aimed at defining linkage specificity in this group
of closely related enzymes.
 |
ACKNOWLEDGEMENTS |
We thank M. Sauerborn for critical remarks on
the manuscript, K. Moremen for kindly providing the -mannosidase II
antiserum, and D. Bitter-Suermann for continuous support.
 |
FOOTNOTES |
*
This work was supported by Deutsche Forschungsgemeinschaft
Grant GE 801/3-2 and European Commission Grant BIO4-CT96-0730.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) X83562 and Z46801 (for murine ST8SiaII and hamster ST8SiaIV, respectively).
¶
To whom correspondence should be addressed. Tel.:
49-511-532-4359; Fax: 49-511-532-4366; E-mail:
gerardy@rgs.mikrobio.mh-hannover.de.
Published, JBC Papers in Press, July 31, 2000, DOI 10.1074/jbc.M003507200
2
M. Mühlenhoff, A. Manegold, M. Windfuhr,
B. Gotza, and R. Gerardy-Schahn, manuscript in preparation.
 |
ABBREVIATIONS |
The abbreviations used are:
NCAM, neural cell
adhesion molecule;
Ig, immunoglobulin;
PSA, polysialic acid;
CHO, Chinese hamster ovary;
mAb, monoclonal antibody;
HA, hemagglutinin;
AP, alkaline phosphatase;
DTAF, dichlorotriazinyl aminofluorescein;
TRITC, tetramethyl rhodamine isothiocyanate;
endoNE, endoneuraminidase NE;
FCS, fetal calf serum;
SSC, standard saline citrate;
RT, reverse
transcription;
PCR, polymerase chain reaction;
PBS, phosphate-buffered
saline;
PAGE, polyacrylamide gel electrophoresis;
wt, wild type;
ER, endoplasmic reticulum.
 |
REFERENCES |
| 1.
|
Ronn, L. C.,
Hartz, B. P.,
and Bock, E.
(1998)
Exp. Gerontol.
33,
853-864
|
| 2.
|
Redies, C.,
and Takeichi, M.
(1996)
Dev. Biol.
180,
413-423
|
| 3.
|
Vestweber, D.,
and Blanks, J. E.
(1999)
Physiol. Rev.
79,
181-213
|
| 4.
|
Walsh, F. S.,
and Doherty, P.
(1996)
Curr. Opin. Cell Biol.
8,
707-713
|
| 5.
|
Walsh, F. S.,
and Doherty, P.
(1997)
Annu. Rev. Cell Dev. Biol.
13,
425-456
|
| 6.
|
Frei, T.,
Bohlen, H. F.,
Wille, W.,
and Schachner, M.
(1992)
J. Cell Biol.
118,
177-194
|
| 7.
|
Rao, Y.,
Wu, X. F.,
Gariepy, J.,
Rutishauser, U.,
and Siu, C. H.
(1992)
J. Cell Biol.
118,
937-949
|
| 8.
|
Kiselyov, V. V.,
Berezin, V.,
Maar, T. E.,
Soroka, V.,
Edvardsen, K.,
Schousboe, A.,
and Bock, E.
(1997)
J. Biol. Chem.
272,
10125-10134
|
| 9.
|
Mühlenhoff, M.,
Eckhardt, M.,
and Gerardy-Schahn, R.
(1998)
Curr. Opin. Struct. Biol.
8,
558-564
|
| 10.
|
Kiss, J. Z.,
and Rougon, G.
(1997)
Curr. Opin. Neurobiol.
7,
640-646
|
| 11.
|
Rutishauser, U.
(1996)
Curr. Opin. Cell Biol.
8,
679-684
|
| 12.
|
Seki, T.,
and Arai, Y.
(1993)
Neurosci. Res.
17,
265-290
|
| 13.
|
Seki, T.,
and Arai, Y.
(1993)
J. Neurosci.
13,
2351-2358
|
| 14.
|
Muller, D.,
Wang, C.,
Skibo, G.,
Toni, N.,
Cremer, H.,
Calaora, V.,
Rougon, G.,
and Kiss, J. Z.
(1996)
Neuron
17,
413-422
|
| 15.
|
Kiss, J. Z.,
Wang, C.,
Olive, S.,
Rougon, G.,
Lang, J.,
Baetens, D.,
Harry, D.,
and Pralong, W. F.
(1994)
EMBO J.
13,
5284-5292
|
| 16.
|
Hu, H.,
Tomasiewicz, H.,
Magnuson, T.,
and Rutishauser, U.
(1996)
Neuron
16,
735-743
|
| 17.
|
Doherty, P.,
Cohen, J.,
and Walsh, F. S.
(1990)
Neuron
5,
209-219
|
| 18.
|
Goridis, C.,
and Brunet, J. F.
(1992)
Semin. Cell Biol.
3,
189-197
|
| 19.
|
Theodosis, D. T.,
Bonhomme, R.,
Vitiello, S.,
Rougon, G.,
and Poulain, D. A.
(1999)
J. Neurosci.
19,
10228-10236
|
| 20.
|
Lantuejoul, S.,
Moro, D.,
Michalides, R. J.,
Brambilla, C.,
and Brambilla, E.
(1998)
Am. J. Surg. Pathol.
22,
1267-1276
|
| 21.
|
Kibbelaar, R. E.,
Moolenaar, C. E.,
Michalides, R. J.,
Bitter-Suermann, D.,
Addis, B. J.,
and Mooi, W. J.
(1989)
J. Pathol.
159,
23-28
|
| 22.
|
Glüer, S.,
Schelp, C.,
Madry, N.,
von Schweinitz, D.,
Eckhardt, M.,
and Gerardy-Schahn, R.
(1998)
Br. J. Cancer
78,
106-110
|
| 23.
|
Hildebrandt, H.,
Becker, C.,
Glüer, S.,
Rosner, H.,
Gerardy-Schahn, R.,
and Rahmann, H.
(1998)
Cancer Res.
58,
779-784
|
| 24.
|
Roth, J.,
Zuber, C.,
Wagner, P.,
Blaha, I.,
Bitter-Suermann, D.,
and Heitz, P. U.
(1988)
Am. J. Pathol.
133,
227-240
|
| 25.
|
Figarella-Branger, D.,
Dubois, C.,
Chauvin, P.,
De Victor, B.,
Gentet, J. C.,
and Rougon, G.
(1996)
J. Clin. Oncol.
14,
2066-2072
|
| 26.
|
Hildebrandt, H.,
Becker, C.,
Murau, M.,
Gerardy-Schahn, R.,
and Rahmann, H.
(1998)
J. Neurochem.
71,
2339-2348
|
| 27.
|
Tsuji, S.
(1996)
J. Biochem. (Tokyo.)
120,
1-13
|
| 28.
|
Kojima, N.,
Tachida, Y.,
and Tsuji, S.
(1997)
J. Biochem. (Tokyo.)
122,
1265-1273
|
| 29.
|
Nakayama, J.,
and Fukuda, M.
(1996)
J. Biol. Chem.
271,
1829-1832
|
| 30.
|
Angata, K.,
Suzuki, M.,
and Fukuda, M.
(1998)
J. Biol. Chem.
273,
28524-28532
|
| 31.
|
Mühlenhoff, M.,
Eckhardt, M.,
Bethe, A.,
Frosch, M.,
and Gerardy-Schahn, R.
(1996)
EMBO J.
15,
6943-6950
|
| 32.
|
Close, B. E.,
and Colley, K. J.
(1998)
J. Biol. Chem.
273,
34586-34593
|
| 33.
|
Close, B. E.,
Tao, K.,
and Colley, K. J.
(2000)
J. Biol. Chem.
275,
4484-4491
|
| 34.
|
Eckhardt, M.,
Mühlenhoff, M.,
Bethe, A.,
Koopman, J.,
Frosch, M.,
and Gerardy-Schahn, R.
(1995)
Nature
373,
715-718
|
| 35.
|
Frosch, M.,
Gorgen, I.,
Boulnois, G. J.,
Timmis, K. N.,
and Bitter-Suermann, D.
(1985)
Proc. Natl. Acad. Sci. U. S. A.
82,
1194-1198
|
| 36.
|
Gerardy-Schahn, R.,
Eckhardt, M.,
Ledermann, J.,
and Kemshead, J. T.
(1994)
Int. J. Cancer Suppl.
8,
27-29
|
| 37.
|
Moremen, K. W.,
Touster, O.,
and Robbins, P. W.
(1991)
J. Biol. Chem.
266,
16876-16885
|
| 38.
|
Gerardy-Schahn, R.,
Bethe, A.,
Brennecke, T.,
Mühlenhoff, M.,
Eckhardt, M.,
Ziesing, S.,
Lottspeich, F.,
and Frosch, M.
(1995)
Mol. Microbiol.
16,
441-450
|
| 39.
|
Sambrook, J.,
Fritsch, E. F.,
and Maniatis, T.
(1989)
Molecular Cloning: A Laboratory Manual
, 2nd Ed.
, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
|
| 40.
|
Sanger, F.,
Nicklen, S.,
and Coulson, A. R.
(1977)
Proc. Natl. Acad. Sci. U. S. A.
74,
5463-5467
|
| 41.
|
Laemmli, U. K.
(1970)
Nature
227,
680-685
|
| 42.
|
Yoshida, Y.,
Kojima, N.,
Kurosawa, N.,
Hamamoto, T.,
and Tsuji, S.
(1995)
J. Biol. Chem.
270,
14628-14633
|
| 43.
|
Moremen, K. W.,
and Touster, O.
(1986)
J. Biol. Chem.
261,
10945-10951
|
| 44.
|
Weisz, O. A.,
Swift, A. M.,
and Machamer, C. E.
(1993)
J. Cell Biol.
122,
1185-1196
|
| 45.
| |